Search
Close this search box.

Fort Walton Medical Center offering antibody infusions for high-risk COVID patients

Fort Walton Beach Medical Center is now offering bamlanivimab antibody infusions to non-hospitalized patients who have tested positive for COVID-19 and have other high-risk factors.  The first patient received the treatment on December 22 making Fort Walton Beach Medical Center the only hospital in the tri-county area to offer this antibody infusion. The FDA granted Emergency Use Authorization […]

Fort Walton Beach Medical Center nurse administering the antibody infusion to a patient.

Fort Walton Beach Medical Center is now offering bamlanivimab antibody infusions to non-hospitalized patients who have tested positive for COVID-19 and have other high-risk factors. 

The first patient received the treatment on December 22 making Fort Walton Beach Medical Center the only hospital in the tri-county area to offer this antibody infusion.

The FDA granted Emergency Use Authorization of bamlanivimab for the treatment of COVID-19 patients experiencing mild to moderate symptoms who are high risk to develop severe COVID-19.  Fort Walton Beach Medical Center will provide the outpatient IV treatment for adults and adolescents age 12 and older.

High-risk conditions that may be eligible for this treatment include:

  • Obesity
  • 65+ years of age
  • Chronic kidney disease
  • COPD
  • Diabetes
  • Immunosuppressive disease
  • Heart disease
  • For children over the age of 12, sickle cell disease, neurodevelopmental disorders, and asthma are also among several additional considerations for eligibility.

“We’re committed to providing our patients, caregivers, and the communities we serve with the latest treatments in the fight against COVID-19 and are excited to bring this option to the tri-county area,” said Dr. Bob Kiskaddon, Chief Medical Officer for Fort Walton Beach Medical Center. “We will support all of our local hospitals in working closely with physicians and other providers across the communities we serve to provide treatment to patients who may benefit, per FDA guidelines.”

The medication supply is limited and based on availability. Patients will need a physician referral and meet FDA criteria prior to scheduling, according to the hospital.  The treatment is a one-time intravenous infusion over the course of one hour followed by an hour of monitoring.

bamlanivimab is not authorized for use for patients who:

  • Are hospitalized due to COVID-19
  • Require oxygen therapy due to COVID-19
  • Require supplemental oxygen for other conditions and require an increase in their oxygen requirement.

For more information on monoclonal antibody treatment for COVID-19, visit the Coronavirus Hub at www.fwbmc.com/covid-19.

Join the conversation...

Continue reading 👇

Community Comments

“Man l wish santa rosa sheriff and the d.a. gave a dang about finding people's stuff here. Detective tift said he was close to finding my property, found the kid...”
Respond
“This brought me to tears, then tears of joy. May Bryce's memory continue to be a blessing. Thank you for the beautiful ways you and your family honor him and...”
Respond
“I worked for Cash in 1977-78 at Bachelor’s. A few nights a week I worked as a DJ and other nights bartending in the pool room. I was trying to...”
Respond
“It won't last. A 2400 square foot coffee shop? Right. I don't think so.”
Respond
“I hope no circumstances ever make me turn out like you and be angry at a news article that doesn’t even apply to you. The fact that you’re doing this...”
Respond
“Wise Counsel … Give Bit Wizards a Call & Your Customers Peace of Mind.”
Respond
“God bless this facility and the injured animals it serves!”
Respond
Tisha (Bimma) Fleet commented on Mini Crossword: Week of May 30, 2025
“Love this feature!! With all of the anesthesia I had last month,I still have brain fog and this helps me exercise it. Kudos to you!”
Respond

GET OUR FREE LOCAL NEWSLETTER

Get the weekday email that actually makes reading local news enjoyable again.